Name | Description | SBIR/STTR Award Recipient | Government Agency | Government Branch | Award Type | Contract Number (US Government) | Award Phase | Award Amount (USD) | Date Awarded | Official Website | ||
---|---|---|---|---|---|---|---|---|---|---|---|---|
A STTR Phase I contract was awarded to VaxNewMO in January, 2022 for $300,000.0 USD from the U.S. Department of Health & Human Services and National Institutes of Health. | STTR | 1R41AI167078-01 | Phase I | 300,000 | January 1, 2022 | |||||||
A STTR Phase I contract was awarded to VaxNewMO in March, 2019 for $300,000.0 USD from the U.S. Department of Health & Human Services and National Institutes of Health. | STTR | 1R41AI142928-01A1 | Phase I | 300,000 | March 12, 2019 | |||||||
A STTR Phase I contract was awarded to VaxNewMO in July, 2022 for $299,238.0 USD from the U.S. Department of Health & Human Services and National Institutes of Health. | STTR | 1R42AI165116-01A1 | Phase I | 299,238 | July 15, 2022 | |||||||
A STTR Phase I contract was awarded to VaxNewMO in December, 2017 for $299,999.0 USD from the U.S. Department of Health & Human Services and National Institutes of Health. | STTR | 1R41AI136233-01 | Phase I | 299,999 | December 20, 2017 | |||||||
A SBIR Phase II contract was awarded to VaxNewMO in February, 2020 for $931,060.0 USD from the U.S. Department of Health & Human Services and National Institutes of Health. | SBIR | 2R44AI131742-02 | Phase II | 931,060 | February 4, 2020 | |||||||
A STTR Phase I contract was awarded to VaxNewMO in February, 2017 for $210,129.0 USD from the U.S. Department of Health & Human Services. | STTR | 1R41AI131742-01 | Phase I | 210,129 | February 22, 2017 | |||||||
A SBIR Phase II contract was awarded to VaxNewMO in June, 2023 for $1,000,000.0 USD from the U.S. Department of Health & Human Services and National Institutes of Health. | SBIR | 2R44AI142928-03A1 | Phase II | 1,000,000 | June 14, 2023 |